Intercostal Cryoablation During Video-Assisted Lung Resection Can Decrease Postoperative Opioid Use.

Autor:	Maxwell CM; Department of General Surgery, Allegheny General Hospital, Pittsburgh, PA, USA., Weksler B; Division of Thoracic and Esophageal Surgery, Allegheny Health Network, Pittsburgh, PA, USA., Houda J; Division of Thoracic and Esophageal Surgery, Allegheny Health Network, Pittsburgh, PA, USA., Fernando HC; Division of Thoracic and Esophageal Surgery, Allegheny Health Network, Pittsburgh, PA, USA.
Jazyk:	angličtina
Zdroj:	Innovations (Philadelphia, Pa.) [Innovations (Phila)] 2023 Jul-Aug; Vol. 18 (4), pp. 352-356. Date of Electronic Publication: 2023 Jul 17.
DOI:	10.1177/15569845231185583
Abstrakt:	Objective: Pain requiring opioid use remains an issue even with minimally invasive thoracic surgery. The objective of this study was to investigate the effectiveness of intercostal nerve cryoablation (CRYO) for pain control in adult patients undergoing pulmonary resection. Methods: A retrospective analysis of patients undergoing pulmonary resection by uniportal video-assisted thoracic (uVATS) approach was undertaken. Patients treated with our usual pain regimen (STANDARD) were compared with those who additionally received CRYO. STANDARD includes intercostal bupivacaine, patient-controlled analgesia (24 h), ketorolac (48 to 72 h), and tramadol. Intraoperative CRYO was performed on 5 intercostal levels. The primary aim was to compare pain scores (range, 0 to 10) and morphine equivalent dosages (MED). Secondary outcomes included length of stay, chest tube duration, presence of an air leak, and adverse events. A p value <0.05 was considered significant. Results: There were 49 patients (34 female, 15 male). The median age was 74 (37 to 90) years. Procedures included lobectomy ( n = 32), segmentectomy ( n = 7), and wedge resections ( n = 10). There were 23 (46.9%) CRYO and 26 (53.1%) STANDARD patients. Baseline characteristics were similar. Mean length of stay (2.9 vs 3.5 days), chest tube duration (2.2 vs 1.8 days), and adverse events (9 of 23 vs 7 of 26) were similar. There were no complications attributable to CRYO. Pain scores were not significantly different on postoperative days (POD) 1 to 4. MED was significantly reduced after CRYO on POD 1 (5 vs 47.24), POD 2 (10.93 vs 25.04), POD 3 (8.13 vs 21.7), and POD 4 (7.08 vs 19.17). Conclusions: CRYO can be performed safely during pulmonary resection and can decrease in-hospital opioid use. The results from this retrospective study will need to be validated in future prospective studies.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu